BioNTech SE (BNTX) Tops Q2 EPS by EUR1.86

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to BioNTech SE (BNTX) Tops Q2 EPS by EUR1.86

BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update

August 9, 2021 7:00 AM EDT

More than one billion doses of BNT162b2 vaccine supplied to more than 100 countries or territories worldwide as of July 21, 2021Signed agreements for approximately 2.2 billion doses of BNT162b2 in 2021 as of July 21, 2021In oncology, the first patients were dosed in randomized Phase 2 trials for two FixVac programs, BNT111 and BNT113, and first-in-human Phase 1 trials started for BNT152+153 and BNT221BioNTechs oncology pipeline has advanced: currently 15 product candidates in 18 ongoing trials

Conference call and webcast scheduled for August 9, 2021, at 8:00 a.m. ET (2:00 p.m. CET)

MAINZ,... More